Cellular Responses of Human Neuroblastoma Cells to 1,3-DMAA Exposure

Authors

  • Maria de Almeida Associate Laboratory i4HB – Institute for Health and Bioeconomy, University Institute of Health Sciences – CESPU, Gandra, Portugal.
  • Andreia Machado Brito-da-Costa UCIBIO - Applied Molecular Biosciences Unit, Translational Toxicology Research Laboratory, University Institute of Health Sciences (1H-TOXRUN, IUCS-CESPU), Gandra, Portugal. https://orcid.org/0000-0001-7327-1598
  • Cláudia Ribeiro UCIBIO - Applied Molecular Biosciences Unit, Translational Toxicology Research Laboratory, University Institute of Health Sciences (1H-TOXRUN, IUCS-CESPU), Gandra, Portugal.
  • Ricardo Jorge Dinis-Oliveira Department of Public Health and Forensic Sciences, and Medical Education, Faculty of Medicine, University of Porto, Porto, Portugal.
  • Diana Cristina Dias da Silva Associate Laboratory i4HB – Institute for Health and Bioeconomy, Laboratory of Toxicology, Faculty of Pharmacy, University of Porto, Porto, Portugal.

DOI:

https://doi.org/10.26537/prpaeh.v4i2.7362

Keywords:

Neurotoxicity, In vitro assay, SH-SY5Y cells

Abstract

Background: Once used as a nasal decongestant until the 1980s, 1,3-dimethylamylamine (1,3-DMAA) was withdrawn from the market due to adverse effects such as headaches, nervousness, psychomotor stimulation, and tremors (1). In 2005, 1,3-DMAA re-emerged on the market and is now found in dietary supplements for appetite suppression, ergogenic aids for athletic performance, and for psychoactive recreational products (2). Despite its controversial use and ban in several competitions, its presence in anti-doping analyses and supplements continues to generate significant concern. Although the toxic effects are known, the neurotoxic impact is still not fully understood (3). Objective: This study aimed to investigate the cytotoxic mechanisms induced by 1,3-DMAA in a human neuronal cell model (SH-SY5Y), contributing to a better understanding of its toxicodynamics. Methods: SH-SY5Y cells were exposed for 48h to 1,3-DMAA (1.3×10⁻⁴ to 1.5×10¹ mM; n=5); mitochondrial metabolic activity was assessed using the MTT assay and the lysosomal integrity through the neutral red uptake (NR) assay. Based on the MTT results, cells were subsequently exposed to the EC20 (4.21 mM), EC40 (4.91 mM), and EC60 (5.59 mM), and changes in intracellular reactive oxygen species (ROS) production and mitochondrial membrane potential (ΔΨm) assessed using fluorometric probes. Autophagic features were evaluated using acridine orange (AO) staining to detect acidic vesicular organelles. Results: 1,3-DMAA induced concentration-dependent cytotoxicity, with a greater impact on mitochondrial function than lysosomal integrity, as evidenced by lower EC50 values in the MTT assay compared to the NR assay (5.24 mM versus 6.36 mM, respectively). 1,3-DMAA induced a concentration-dependent increase in intracellular ROS levels from EC20 (236.67%; p<0.001) and EC40 (211.87%; p<0.01) and peaking at EC60 (272.05%; p<0.0001). In contrast, ΔΨm remained unchanged at lower concentrations, with a significant increase observed at EC60 (317.32%; p<0.0001). AO staining showed increased acidic vesicular organelles, also at higher concentrations. Conclusions: The concomitant increase in ROS and mitochondrial hyperpolarization indicate a pro-oxidant state. The increase in acidic vesicular organelles suggests activation of autophagic processes and/or progression toward apoptosis. These findings provide mechanistic insights into 1,3-DMAA-induced neurotoxicity and establish a foundation for further toxicological investigations.

References

1. Pawar RS, Tamta H, Ma J, Krynitsky AJ, Grundel E, Wamer WG, et al. Updates on chemical and biological research on botanical ingredients in dietary supplements. Anal Bioanal Chem. 2013;405(13):4373–84.

2. Rodrigues AN, Dinis-Oliveira RJ. Pharmacokinetic and Toxicological Aspects of 1,3-Dimethylamylamine with Clinical and Forensic Relevance. Psychoactives. 2023;2(3):222–41.

3. Small C, Cheng MH, Belay SS, Bulloch SL, Zimmerman B, Sorkin A, et al. The Alkylamine Stimulant 1,3-Dimethylamylamine Exhibits Substrate-Like Regulation of Dopamine Transporter Function and Localization. J Pharmacol Exp Ther. 2023;386(2):266–73.

4. Schilling BK, Hammond KG, Bloomer RJ, Presley CS, Yates CR. Physiological and pharmacokinetic effects of oral 1,3-dimethylamylamine administration in men. BMC Pharmacol Toxicol. 2013;14(1):52. doi:10.1186/2050-6511-14-52

Downloads

Published

2026-10-06

How to Cite

de Almeida, M., Machado Brito-da-Costa, A., Ribeiro, C., Dinis-Oliveira, R. J., & Dias da Silva, D. C. (2026). Cellular Responses of Human Neuroblastoma Cells to 1,3-DMAA Exposure. Proceedings of Research and Practice in Allied and Environmental Health, 4(2), 21–22. https://doi.org/10.26537/prpaeh.v4i2.7362

Most read articles by the same author(s)

Similar Articles

1 2 3 4 5 > >> 

You may also start an advanced similarity search for this article.